SMAD4 and hereditary hemorrhagic telangiectasia: Study patients appeared similar to typical HHT patients with these types of complications, with a mean age in the fifties and the population divided equally between men and women, as well as ENG and ACVRL1 gene mutations, with one patient with the rarer SMAD4 gene involvement.